Home/Filings/4/0000059478-24-000048
4//SEC Filing

Ricks David A 4

Accession 0000059478-24-000048

CIK 0000059478other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 4:31 PM ET

Size

9.1 KB

Accession

0000059478-24-000048

Insider Transaction Report

Form 4
Period: 2024-02-12
Ricks David A
SVP and Pres, Lilly Bio-Meds
Transactions
  • Award

    Common Stock

    2024-02-12$737.26/sh+38,392$28,304,886479,250 total
  • Award

    Restricted Stock Unit

    2024-02-12+26,56126,561 total
    From: 2025-02-01Exp: 2025-02-01Common Stock (26,561 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    7,223
  • Common Stock

    (indirect: By David A. Ricks SLAT)
    68,656
  • Common Stock

    (indirect: By David A. Ricks 2022 GRAT)
    63,758
Footnotes (2)
  • [F1]The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

Issuer

ELI LILLY & Co

CIK 0000059478

Entity typeother

Related Parties

1
  • filerCIK 0001538604

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:31 PM ET
Size
9.1 KB